GP-Act III Acquisition Corp. conducted an extraordinary general meeting on November 12, 2026, to address critical amendments regarding its operational timeline and trust account. Shareholders voted to approve extensions for both the business-combination deadline and the liquidation date of the company’s trust account.

During the voting process, a substantial number of shareholders exercised their redemption rights, which resulted in a reduction of the total trust account balance. To mitigate the impact of these redemptions and support the approved extensions, the company’s sponsor entered into non-redemption agreements with select investors. Under these agreements, investors received additional shares in exchange for committing to forgo their redemption rights and supporting the extension measures.

In related regulatory developments, a third-party reporting firm disclosed a 7.9% stake in the company via a Schedule 13G/A filing, signaling ongoing interest from external investors.

The company’s proposed business combination with Dronamics remains pending. Final approval for this transaction is subject to a separate shareholder meeting, and a registration statement regarding the merger is expected to be filed later this year.

As of the market close on November 12, 2026, GP-Act III Acquisition Corp. (Nasdaq) was priced at 10.92 USD, with a market capitalization of 178,900,000 USD. The stock has traded between a 52-week low of 10.65 USD and a 52-week high of 12.00 USD.